Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study

Sex Transm Dis. 2011 Sep;38(9):879-81. doi: 10.1097/OLQ.0b013e31821f918c.

Abstract

PEACH trial data were used to evaluate the relationship between subsequent sexually transmitted infection and recurrent pelvic inflammatory disease on infertility and chronic pelvic pain (CPP). Recurrent pelvic inflammatory disease was associated with an almost 2-fold increase in infertility and more than 4-fold increase in CPP. Subsequent sexually transmitted infection was associated with CPP, but not infertility.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Cefoxitin / administration & dosage
  • Chronic Pain / complications*
  • Chronic Pain / epidemiology
  • Doxycycline / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Infertility, Female / complications*
  • Infertility, Female / epidemiology
  • Pelvic Inflammatory Disease / complications*
  • Pelvic Inflammatory Disease / epidemiology
  • Pelvic Pain / complications*
  • Pelvic Pain / epidemiology
  • Pregnancy
  • Pregnancy Complications
  • Probenecid / administration & dosage
  • Recurrence
  • Reproductive Health
  • Sexually Transmitted Diseases / complications*
  • Sexually Transmitted Diseases / epidemiology
  • Treatment Outcome
  • United States / epidemiology
  • Uricosuric Agents / administration & dosage
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Uricosuric Agents
  • Cefoxitin
  • Doxycycline
  • Probenecid